Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Clinical Oncology-2018

About The Conference

ConferenceSeries Ltd  is overwhelmed to welcome all the interested participants to its Global conference on Oncology and Radiology during June 1-2, 2018 Osaka, Japan

The conference will be organized around the theme: Cancer Radiology - The Future Shape of  Specialty .This  is an event that brings together active researchers, intellectuals, academicians, students, contributors and industrialists to exchange ideas communicate and discuss research findings on new advancements in all kinds of available anticancer therapies worldwide .This is a two day multidisciplinary meeting covering all aspects of Cancer Therapies and Radiation Oncology, including clinical service delivery, management, informatics and research.

Radiation Oncology is a medical specialty that involves treating cancer with radiation. Doctors who specialize in treating cancer with radiation (radiation oncologists) use radiation therapy to treat a wide variety of cancers. Radiation therapy uses carefully targeted and regulated doses of high-energy radiation to kill cancer cells. Radiation kills cancer cells by damaging the chromosomes and DNA so that the cells can no longer divide and the tumor can't grow. The discussion extends to all available Anti-cancer Therapies like Surgical Therapy, Chemotherapy, Adjuvant Therapy, Neoadjuvant Therapy, Immunotherapy, Hormonal Therapy, Proton Beam Therapy, Phototherapy, Stem Cell Therapy and Alternative Medicine.

Conference Series along with its subsidiary ConferenceSeries Ltd  which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globeConference series hosts numerous Cancer Conferences,Cancer meeting, global cancer conference, European Oncology Conferences, Surgical oncology like skin cancer conference, breast cancer conference, liver cancer conference, lung cancer meetings, and Oncology Conferences where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions and which helps get possibilities for treating the diseases with new era, technology and research.

Why to attend?

With members from around the world focused on learning about Oncologists; this is your best opportunity to reach the largest assemblage of participants from the Oncologists community, oncology society, European oncology conferences, American oncology society. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Oncology are hallmarks of this conference.

Target Audience

·         Oncologists

·         Radiologists

·         Pathologists

·         Hematologists

·         Academicians

·         Research Scholars

·         Students

·         Hematology Associations & Societies

·         Business Entrepreneurs

·         Software Developing Companies

·         Medical Devices Companies

·         Biomedical Companies

·         Biotechnology Companies

·         Data Management Companies

Sessions & Tracks

Track 1:  Radiation Oncology

The branch of Oncology dealing with Radiation therapy is termed as Radiation Oncology. The Radiotherapy is broadly segmented into Teleradiotherapy, Brachy-radiotherapy and Metabolic Radiotherapy. Tele-radiotherapy, also called as External transcutaneous / distant radiotherapy, is a method in which the radiation source is situated at a certain distance from the tissue to be treated. Brachytherapy, also termed as Short direct radiotherapy /Curitherapy, is a method in which radiation source can be placed in contact with the tumor or it can be implanted in the tumor. Curative radiotherapy is indicated to be used in: Sticker’s sarcoma, Mastocytomas with particular locations, such as ears, nose, extremities, eyelids; Nasal cavity adenocarcinoma and Anal gland adenocarcinoma. Stereotactic radiosurgery is a single-day procedure for treating small intracranial lesions. Metabolic radiotherapy represents the administration of isotopes or isotope carrying molecules that selectively concentrate in a certain tissue into which they enter as metabolites. For Example; iodine-131is used in treating Thyroid cancer; phosphorus-32 is used in treating Myeloproliferative disorders.

Related conference: Oncology Conference |Clinical Oncology Conferences |cancer Conference| Oncologist conference|CME conferences |Asia pacific |Osaka |Japan |2018

22ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; 15th Global Annual Oncologists Meeting, October 19-20, 2017 New York, USA; 9th International Cancer Biomarkers Conference, October 26-28, 2017 Osaka,Japan; Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers ,August 23-24, 2017 Birmingham, UK; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, International Conference on Epigenetics 2017, November 13-15, 2017

 

Track 2: Clinical Oncology

Clinical oncology embraces the non-surgical aspect of oncology. It covers both the therapeutic administration of ionizing radiation i.e. radiotherapy and cytotoxic chemotherapy. Clinical oncology is a major participant in any multi-disciplinary team, which would meet regularly to discuss site specific cases of tumours. Other members would be site specific surgeon, palliative care physician, radiologist, pathologist, specialist nursing staff and appropriate haematologist and medical oncologist. Radiotherapy is the administration of ionizing radiation predominantly by external beam (teletherapy) but is also using the more technical operative implantation of interstitial sources, which are often after loaded with radioactive material, e.g. Iridium. There is, therefore, close liaison with postgraduate physicists and scope for great technological understanding with computer planning, etc. Consultants are increasingly site specialized and are based in a cancer centre often visiting peripheral cancer units. 
Clinical oncology is very patient orientated. This specialty gives the opportunity of developing clinical and scientific skills with great potential for academic and clinical research. Furthermore, there are increasing opportunities to take part in National and International Research Trials. 
Clinical oncology is a specialist discipline within radiology. The primary role of the clinical oncologist is the completion of the radiation treatment for cancer patients. Radiation is used to kill the cancer cells within the body. The extent of treatment depends on the type of cancer, degree of progression, and the timing of the diagnosis. Typically, cancer patients who have late stage cancer are not ideal candidates for radiation therapy. 

Related conference: Oncology Conference |Clinical Oncology Conferences |cancer Conference| Oncologist conference|CME conferences |Asia pacific |Osaka |Japan |2018

22ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; 15th Global Annual Oncologists Meeting, October 19-20, 2017 New York, USA; 9th International Cancer Biomarkers Conference, October 26-28, 2017 Osaka,Japan; Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers ,August 23-24, 2017 Birmingham, UK; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, International Conference on Epigenetics 2017, November 13-15, 2017

 

Track 3 : Oncology Nursing

Oncology is a standout amongst the most Focused zone in Cancer Treatments. For an Oncologist or Oncology Nurse, to locate an appropriate words to cheer a man who enduring with sickness. The specific medical caretaker is an enrolled nurture whose essential concentration in tumor mind. This medical caretaker has development strength learning, expertise, and practices in a domain where the lion's share of element has determination of tumor or at danger of advance malignancy. The advanced Oncology Nurse is master’s prepared nurse with learning and capacity in a range of malignancy nursing. All medical caretakers move along a way from learners to master. It is perceived that, paying little respect to regardless of the possibility that a generalist, specific oncology or propelled Oncology Nurse, every individual medical attendant will encounter this way from amateurs to master.

Related conference:Oncology Conference |Clinical Oncology Conferences |cancer Conference| Oncologist conference|CME conferences |Asia pacific |Osaka |Japan |2018

22ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; 15th Global Annual Oncologists Meeting, October 19-20, 2017 New York, USA; 9th International Cancer Biomarkers Conference, October 26-28, 2017 Osaka,Japan; Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers ,August 23-24, 2017 Birmingham, UK; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, International Conference on Epigenetics 2017, November 13-15, 2017

 

 

Track 4: Cancer Therapies

Cancer rates are daily increasing particularly in the developed world. Many cancers are associated with longevity, and as life expectancy increase the risk on patients and payers will increase. Major advances in cellular biology, genetics, pharmacology and immunology in the past ten years are beginning to be translated into progress in cancer treatment. This progress is manifested by new cell killing drugs which have recently entered clinical practice. Tumour angiogenesis as a target is being studied in several clinical trials. The emerging field of genomics and gene expression micro-arrays will provide extensive information about the biology of cancers. This is the most prestigious conference across all the Cancer Conferences and Oncology Conferences

Related conference: Oncology Conference |Clinical Oncology Conferences |cancer Conference| Oncologist conference|CME conferences |Asia pacific |Osaka |Japan |2018

22ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; 15th Global Annual Oncologists Meeting, October 19-20, 2017 New York, USA; 9th International Cancer Biomarkers Conference, October 26-28, 2017 Osaka,Japan; Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers ,August 23-24, 2017 Birmingham, UK; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, International Conference on Epigenetics 2017, November 13-15, 2017

 

Track 5 : Organ-Defined Cancers:

There are about 200 different types of cancer, but they all start as a result of the out-of-control growth of abnormal cells. Cancers are classified in two ways: by the type of tissue in which the cancer originates (histological classification) or by the location or organ in the body where the cancer first developed.

Related conference: Oncology Conference |Clinical Oncology Conferences |cancer Conference| Oncologist conference|CME conferences |Asia pacific |Osaka |Japan |2018

22ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; 15th Global Annual Oncologists Meeting, October 19-20, 2017 New York, USA; 9th International Cancer Biomarkers Conference, October 26-28, 2017 Osaka,Japan; Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers ,August 23-24, 2017 Birmingham, UK; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, International Conference on Epigenetics 2017, November 13-15, 2017

 

Track 6 : Stages of cancer

The cells that generate cancer cells begin to divide more vigorously than usual. As the cancer progresses, tissue that has become malignant continues to alter and become more malignant. The tumour cells become differentiated and the body’s regulatory system is no longer able to control the changes taking place, and so eventually the cancerous tissue begins to spread.Cancer begins to cause damage to the body by growing locally, metastasising in different organs and causing a variety of general symptoms. A malignant tumour can become sizeable at its primary site and harm the normal functioning of the organ in question. The tumour can also displace neighbouring organs, causing pain and pressure symptoms.

Cancer is divided into five stages using the TNM system – 0, I, II, III, IV. Stage 0 means the presence of a small carcinoma in situ that has not spread. Stage IV means cancer that has spread widely or cancer that has metastasised. In some cases the stages have subclasses

Related conference: Oncology Conference |Clinical Oncology Conferences |cancer Conference| Oncologist conference|CME conferences |Asia pacific |Osaka |Japan |2018

22ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; 15th Global Annual Oncologists Meeting, October 19-20, 2017 New York, USA; 9th International Cancer Biomarkers Conference, October 26-28, 2017 Osaka,Japan; Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers ,August 23-24, 2017 Birmingham, UK; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, International Conference on Epigenetics 2017, November 13-15, 2017

 

Track 7: Cancer Biomarkers

With the emergence of genomic profiling technologies and selective molecular targeted therapies, biomarkers play an increasingly important role in the clinical management of cancer patients. Single gene/protein or multi-gene “signature”-based assays have been introduced to measure specific molecular pathway deregulations that guide therapeutic decision-making as predictive biomarkers. Genome-based prognostic biomarkers are also available for several cancer types for potential incorporation into clinical prognostic staging systems or practice guidelines. However, there is still a large gap between initial biomarker discovery studies and their clinical translation due to the challenges in the process of cancer biomarker development.

Related conference: Oncology Conference |Clinical Oncology Conferences |cancer Conference| Oncologist conference|CME conferences |Asia pacific |Osaka |Japan |2018

22ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; 15th Global Annual Oncologists Meeting, October 19-20, 2017 New York, USA; 9th International Cancer Biomarkers Conference, October 26-28, 2017 Osaka,Japan; Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers ,August 23-24, 2017 Birmingham, UK; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, International Conference on Epigenetics 2017, November 13-15, 2017

 

Track 8: Cancer Screening Test

Prostate screening tests consist of Digital rectal exam (DRE) and Prostate-specific antigen (PSA) test. Screening increases the capacity of detecting certain cancers early when they are most likely to be curable. Learn what screening tests the American Cancer associations suggests, when you should have them, and how they are covered under some types of cancer therapies. Mammograms are used to analyses breast cancer in women who have no signs or symptoms of the disease. Cancer screening Oncolytic is an exciting, increasingly recognized discipline in cancer research which will be discussed in upcoming cancer conferences.

Related conference: Oncology Conference |Clinical Oncology Conferences |cancer Conference| Oncologist conference|CME conferences |Asia pacific |Osaka |Japan |2018

22ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; 15th Global Annual Oncologists Meeting, October 19-20, 2017 New York, USA; 9th International Cancer Biomarkers Conference, October 26-28, 2017 Osaka,Japan; Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers ,August 23-24, 2017 Birmingham, UK; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, International Conference on Epigenetics 2017, November 13-15, 2017

 

Track 9: Stem Cell

Stem cells: An undifferentiated cell of a multicellular cell which is capable of giving rise to indefinitely more cells of the same type, and from which certain other kinds of cell arise by differentiation. Stem cells have the ability to differentiate into specific cell types. The two defining characteristics of a stem cell are perpetual self-renewal and the ability to differentiate into a specialized adult cell type. There are two major classes of stem cells: pluripotent that can become any cell in the adult body, and multipotent those are restricted to becoming a more limited population of cells.

Related conference: Oncology Conference |Clinical Oncology Conferences |cancer Conference| Oncologist conference|CME conferences |Asia pacific |Osaka |Japan |2018

22ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; 15th Global Annual Oncologists Meeting, October 19-20, 2017 New York, USA; 9th International Cancer Biomarkers Conference, October 26-28, 2017 Osaka,Japan; Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers ,August 23-24, 2017 Birmingham, UK; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, International Conference on Epigenetics 2017, November 13-15, 2017

 

Track 10: Cancer Biopsy

A biopsy is a method of removing a piece of tissue or a sample of cells from your body so that it can be analyzed in a laboratory. When an entire lump or suspicious area is removed, the method is called an excisional biopsy. When only a piece of tissue is removed with preservation of the histological architecture of the tissue’s cells, the method is called an incisional biopsy or core biopsy. Fine needle aspiration (FNA) is a type of biopsy procedure, most often done on swellings or lumps located just under the skin. Endoscopic biopsy is most often used in gastric cancers to remove the tissues for examination. CT-guided biopsy is a procedure by which the physician uses a very thin needle and a syringe to withdraw a tissue or fluid specimen from an organ or suspected tumor mass. Ultrasound-guided biopsy which involves the removal of cells from a suspicious area within the body using a thin needle and hollow tube called a syringe. Ultrasound is used by the physician to guide the needle to the appropriate area.

Related conference: Oncology Conference |Clinical Oncology Conferences |cancer Conference| Oncologist conference|CME conferences |Asia pacific |Osaka |Japan |2018

22ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; 15th Global Annual Oncologists Meeting, October 19-20, 2017 New York, USA; 9th International Cancer Biomarkers Conference, October 26-28, 2017 Osaka,Japan; Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers ,August 23-24, 2017 Birmingham, UK; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, International Conference on Epigenetics 2017, November 13-15, 2017

 

Track 11: Alternative Medicine

Alternative medicine or fringe medicine are practices asserted to have the healing effects of medicine however are disproven, problematic, difficult to demonstrate, or just harmful. Alternative medicine has developed in prevalence and is utilized by a critical rate of the populace in numerous nations. While it has widely rebranded itself: from misrepresentation to correlative or integrative pharmaceutical—it advances basically similar practices. In any case, critical medication communications brought about by option treatments may rather contrarily impact medicines, making them less successful, eminently disease treatment. In the UK corresponding treatments are ordinarily made accessible to cancer patients. Alternative medicine has been criticized for being based on misleading statements, deception, pseudoscience, antiscience, extortion, or poor logical philosophy.

Inspite of all these Alternative medicine has few advantages: Many individuals swing to Alternative medicine treatments for pain relief when traditional treatments neglect to work. Alternative medicine offers treatment choices to people who do not have access to pain clinics under their medical coverage arranges, Alternative medicine treatments utilized together with traditional medicinal medications can reduce a portion of the manifestations of cancer, and decrease the antagonistic symptoms of customary restorative medications. Alternative medicine treatments can be less costly than routine therapeutic medicines. As a rule, compelling option treatments have less or no reactions rather than the regular and at times serious impacts of numerous professionally prescribed pharmaceuticals and other routine medicinal medications. Alternative medicine can be valuable to a man's general prosperity, as the approach concentrates on recuperating the psyche, body and soul.

Related conference: Oncology Conference |Clinical Oncology Conferences |cancer Conference| Oncologist conference|CME conferences |Asia pacific |Osaka |Japan |2018

22ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; 15th Global Annual Oncologists Meeting, October 19-20, 2017 New York, USA; 9th International Cancer Biomarkers Conference, October 26-28, 2017 Osaka,Japan; Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers ,August 23-24, 2017 Birmingham, UK; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, International Conference on Epigenetics 2017, November 13-15, 2017

 

Track 12: Oncologist Meet

The cancer study is called as Oncology. A person who specializes in the study of oncology and treating people with cancer is known as oncologist. An oncologist shows dedicative care towards treatment once a person is suffering from cancer. There are about 2900 oncologists in Germany, and 8000 oncologists in USA, around 9500 oncologists in Europe and 1500 eminent oncologists from different parts of Asia.

Related conference: Oncology Conference |Clinical Oncology Conferences |cancer Conference| Oncologist conference|CME conferences |Asia pacific |Osaka |Japan |2018

22ndGlobal Annual Oncologists Meeting, May 24-25, 2017 Osaka, Japan; 15th Global Annual Oncologists Meeting, October 19-20, 2017 New York, USA; 9th International Cancer Biomarkers Conference, October 26-28, 2017 Osaka,Japan; Gynecologic Oncology & Preventive Oncology, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE; Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; 9th International Conference Cancer Biomarkers ,August 23-24, 2017 Birmingham, UK; 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, International Conference on Epigenetics 2017, November 13-15, 2017

 

 

Market Analysis

Market Analysis for Oncology 2018,Japan

Oncology is the term used for the study of the cancer and it is branch of medicine. Doctor who specializes in the Oncology is known as Oncologist. The vital role of the oncologist is to diagnose the people who are suffering from the cancer and explain the adverse effects during the treatment. There are different types of Oncologists in treating the cancer. Medical Oncologist treats the cancer with the chemotherapy process. Surgical Oncologist involves in the removal of the tumour and the surrounded tissue during the surgery. Radiation Oncologist used to treat the cancer with the Radiation therapy.

Cancer is a common term for a large group of diseases that can affect any organ of the body. Other terms used are malignant tumours and neoplasms. One of the significant features of cancer is the rapid creation of abnormal cells that grow beyond their usual margins, and which can then attack the adjoining parts of the body and spread to other organs. This process is referred to as metastasis. They are the major cause of death from cancer. Tobacco use, alcohol use, unhealthy diet and physical inactivity are the main cancer risk factors worldwide. Chronic infections from hepatitis B (HBV), hepatitis C virus (HCV) and some types of Kaposi’s sarcoma are leading risk factors for cancer in low- and middle-income countries.

Scope and Importance

Cancer is the second leading cause of death worldwide and in all regions of the world. It has undergone a period of dramatic economic, social, and demographic change, resulting in increased life expectancy and prosperity.

Cancer is the leading cause of death in the Dubai. The incidence of all cancers is projected to 20% increase by 2010-2030, primarily due to ageing and also possibly due to increased exposure to risk factors for cancer. Breast cancer is the most common cancer among UAE females (and the most prevalent cancer in both sexes combined), lung cancer, prostate cancer and bowel caners are the most common cancers amongst males but is extremely rare in females, which reflects the prevalence of smoking (23.0% vs. 0.5%, respectively).

According to 2012 statistics approximately 14.1 million cases are reported and 8.2 million deaths are reported. Lung, Liver, Stomach and bowel cancers cause the most common deaths among the worldwide that accounts nearly half of all the cancer deaths. About 70% increasein the cases are to be expected over the next 2 decades. In males 5 most common sites of cancer are diagnosed in 2012 were lung, prostate, colorectal and liver cancers. In females 5 most common sites diagnosed were breast, colorectal, cervix, lung and stomach cancer. Breast cancer, the most common tumor in women, presents a high survival percentage: 83% of patients have survived this type of cancer after five years.

Cervical cancer is the third most commonly diagnosed cancer and the fourth leading cause of cancer death in females’ worldwide, accounting for 9% (529,800) of the total new cancer cases and 8% (275,100) of the total cancer deaths among females. More than 85% of these cases and deaths occur in developing countries.

Lung cancer is one of the most aggressive tumors and survival after five years is   very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years.

Colorectal cancer (of the colon and rectum), the most common malignant tumors if we group men and women together, presents an average survival rate of 50-55% five years after diagnosis, meaning that half the patients survive this form of cancer.Prostate cancer, today the most common tumors in men, has an increasingly favorable prognosis, with a global survival rate of 76%, which is higher in young adults.

Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.

Oncology Conferences are intended to provide a medium for the communication of results and ideas in the field of cancer science and Treatment regarding to cancers. The conference welcomes contributions in both the basic and clinical aspects of the cancer science and special sections on the Health Care and a forum for Innovative topics related to the cancer science.

Oncologists 2016 will be the best platform for oncologists, radiologists, pathologists, Immunologists researchers working in this field to connect and exchange ideas.

ConferenceSeries Ltd welcomes all the oncologists, radiologists, pathologists, Immunologists research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of the esteemed Oncologists. As this will be the best amalgamation of academia and research involving every aspect and advances in the field of Oncology & cancer. It is open to all types of research methodologies both from academia and industry

Why Japan?  

Japan is considered as an important centre for higher education and harbours, healthcare, well reputed and prestigious colleges and Universities. It can be considered as a suitable medium for the relocation of valuable knowledge about research and novel advancements worldwide. The conferences taking part here would promote a variety of scientific ideas among contenders belonging to diverse areas of science and technology. Japanese outcomes for high level medical treatment are generally competitive with that of the US. A comparison of two reports in the New England Journal of Medicine  suggest that outcomes for gastro-oesophageal cancer is better in Japan than the US in both patients treated with surgery alone and surgery followed by chemotherapy. Japan excels in the five-year survival rates of colon cancer, lung cancer, pancreatic cancer and liver cancer based on the comparison of a report by the American Association of Oncology and another report by the Japan Foundation for the Promotion of Cancer research. The same comparison shows that the US excels in the five-year survival of rectal cancer, breast cancer, prostate cancer and malignant lymphoma. Surgical outcomes tend to be better in Japan for most cancers while overall survival tend to be longer in the US due to the more aggressive use of chemotherapy in late stage cancers. A comparison of the data from United States Renal Data System (USRDS) 2009 and Japan Reno logy Society 2009 shows that the annual mortality of patients undergoing dialysis in Japan is 13% compared to 22.4% in the US. Five-year survival of patients under dialysis is 59.9% in Japan and 38% in the US.

   Cancer Universities in Japan

  • National Cancer Centre Hospital
  • Aichi Cancer Centre
  • Kyoto Prefectural University of Medicine
  • Tohoku University
  • Kyoto University
  • Chiba University
  • Osaka University

Universities Worldwide

  •  University of Oxford
  • University of Cambridge
  • UCL London's Global University
  • Stanford University
  • Western University
  • University of Nottingham
  • University of Bologna
  • University of Athens
  • University of Chicago
  • University of Washington
  • University of Rochester
  • The University of Melbourne
  • University of Glasgow
  • Fudan University
  • Stanford University
  • University of Minnesota
  • University of Albert
  • University of Nebraska
  • University of Iowa Carver
  • University of Pennsylvania
  • South-western University
  • University of Pittsburgh
  • University of Helsinki
  • University of Penn Medicine

  Universities in Asia

  • Osaka University
  • Tsinghua University
  • Fudan University
  • Taipei Medical University
  • KAIST - Korea Advanced Institute of Science and Technology
  • Yonsei University
  • Shanghai Jiao Tong University
  • Nanyang Technological University (NTU)
  • Chulalongkorn Universit
  • Tohoku University
  • Tokyo Medical and Dental University
  • Kyushu University
  • Nagoya University
  • Hokkaido University
  • Sungkyunkwan Universit
  •  Indian Institute of Science
  • University Kebangsaan Malaysia (UKM)
  • University Saints Malaysia (USM)
  • Beijing University of Chinese Medicine
  • National Tsing Hua University

Associations in Japan 

  • The Japanese Breast Cancer Society
  • The Japanese Cancer Association
  • Japan Society of Clinical Oncology
  • Japanese Gastric Cancer Association
  • The Japanese Society of Hematology
  • The Japan Lung Cancer Society
  •  Japanese Society of Medical Oncology (JSMO)
  • The Japanese Society of Paediatric Hematology/Oncology
  • Japan Primary Care Association

 Associations Worldwide

  • Life South Community Blood Centre
  • World congress of the International society of Hematology
  • International society of Hematology
  • World federation of Haemophilia
  • European Hematology Associations
  • Malaysian society of Hematology
  • Armenian associations of Hematology & Oncology
  • Japanese society of Hematology
  • Japan Primary Care Association

  Association in Asia Pacific

  • The Asia-Pacific Urogynecology Association
  • The Asia-Pacific Cancer Society Training
  • Asian Cancer Foundation India
  • The Max Foundation
  • Childhood Cancer International Netherlands
  • The Asia Pacific Prostate Society

Pharmaceutics company in Japan

  • Takeda
  • Otsuka
  • Meiji   
  • Daiichi Sankyo
  • Astellas
  • Teijin
  • Chugai  
  •  Mitsubishi Tanabe    
  •  Kyowa Hakko Kirin  
  • Taisho
  • Shionogi
  •  Ono        
  •  Hisamitsu
  • Santel
  • Kyorin
  • Nichi-Iko
  • Mochida
  •  Kaken   
  •  Sawai    
  •  Kissei    
  •  Towa     
  •  Zeria      
  •  Torii              
  •  takedaDaito

     Cancer hospitals in Japan

  • St Luke's International Hospital
  • National Cancer Centre Hospital, Tokyo ,Japan
  • Japan Red Cross Medical Centre
  • Shizuoka Cancer Centre
  • Chiba university hospital

     Cancer hospitals worldwide

  •  Leiden University Medical Centre
  • Royal Cancer Hospital
  • King’s College Hospital
  • Clatter bridge Centre for Oncology
  • Northampton General Hospital
  • Cambridge University Hospitals
  • University Hospital Southampton
  • Central Manchester University Hospitals

 

Oncology Journals Impact Factors List

Cancer rates are daily increasing particularly in the developed world. Many cancers are associated with longevity, and as life expectancy increase the risk on patients and payers will increase. Major advances in cellular biology, genetics, pharmacology and immunology in the past ten years are beginning to be translated into progress in cancer treatment. This progress is manifested by new cell killing drugs which have recently entered clinical practice. Tumour angiogenesis as a target is being studied in several clinical trials. The emerging field of genomics and gene expression micro-arrays will provide extensive information about the biology of cancers. This is the most prestigious conference across all the Cancer Conferences and Oncology Conferences

Oncology and Radiology conference creates a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing

Speakers and other participants of  Oncology Conference  get an offer of 30% waiver on publication fee. Do not miss the opportunity of publishing your research at right place and make sure your research reaches the right industry through OPEN ACCESS Journals

Oncology Journals Impact Factors List

Journal Name

Journal Impact Factor*

Citations Report

Journal of Carcinogenesis & Mutagenesis

1.09

2.50 (5 Yr Journal Impact Factor)

Citations Report

Journal of Cancer Science & Therapy

3.09

1.22 (5 Yr Journal Impact Factor)

Citations Report

Journal of Nuclear Medicine & Radiation Therapy

2.15

1.02 (5 Yr Journal Impact Factor)

Citations Report

Journal of Integrative Oncology

1.80

0.74 (5 Yr Journal Impact Factor)

Citations Report

Journal of Clinical Case Reports

0.54

0.47 (5 Yr Journal Impact Factor)

Citations Report

Journal of Leukemia

1.25

Citations Report

OMICS Journal of Radiology

1.13

Citations Report

Chemotherapy: Open Access

1.64

Citations Report

Archives in Cancer Research

0.6

Citations Report

Journal of Clinical & Experimental Oncology

0.264

Citations Report

 

   

 

To Collaborate Scientific Professionals around the World

Conference Date June 1-2, 2018

Speaker Opportunity

Supported By

Journal of Cancer Science & Therapy Journal of Integrative Oncology Contemporary Issues in Women Cancers & Oncology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos